Clinical Trials
4 trialsNCT00321893 2016-01-25
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT02504801 2015-07-22
Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD
Xuanwu Hospital, Beijing
Phase 4 Unknown
NCT00569712 2012-03-09
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
British Columbia Cancer Agency
Phase 1 Completed
NCT00005880 2008-07-24
Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed